A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Completed · Phase 3 · Has a placebo group

Conditions studied: Glycogen Storage Disease Type IA

In brief

The primary objectives of this study are to evaluate the efficacy of DTX401 to reduce or eliminate dependence on exogenous glucose replacement therapy to maintain euglycemia and to maintain or improve the quality of glucose control.

Key facts

Study ID
NCT05139316
Run by
Ultragenyx Pharmaceutical Inc
People needed
49
Starts
2021-11-08
Expected to finish
2026-02-20
Last updated by the study team
2026-03-25

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.